Abstracts

Pharmacokinetics of Once-Daily DTG/3TC FDC in Children Living With HIV: D3/PENTA21 Sub-Study

Background: There is an increasing emphasis on reducing toxicity and improving acceptability of HIV-treatment. Two-drug regimens, consisting of two different antiretroviral drug classes, are recommended as an alternative to standard three-drug regimens, with dolutegravir and lamivudine (DTG/3TC) included in a number of adult treatment guidelines. This nested pharmacokinetics (PK) sub-study within the D3/Penta21 randomized controlled…

High Proportions of Adverse Births in Women With HIV and Non-Communicable Disease Comorbidities

Background: HIV/antiretroviral therapy (ART) and non-communicable diseases (NCDs) like hypertension, diabetes and obesity are independently implicated in poor pregnancy outcomes. However, there is limited data on the interplay of HIV/ART and these NCDs, and associations with adverse birth outcomes in South African women. Methods: In a retrospective study in an urban primary care antenatal care…

Changes in Body Composition During Pregnancy in South African Women Living With HIV on ART

Background: Despite widespread interest in how HIV and antiretroviral therapy (ART) affects weight and body composition there are few data from women living with HIV (WLH), and none from pregnant populations, in sub-Saharan Africa. Methods: In the Obesogenic oRigins of maternal and Child metabolic Health Involving Dolutegravir (ORCHID) study, we explored the relationship between HIV…

Pregnancy Inflammatory Markers Predict Postpartum Weight in South African People Living With HIV

Background: Postpartum weight (PPW) contributes to long-term obesity, a growing concern in women living with HIV (WLH) characterised by low-grade inflammation. We hypothesised that inflammatory markers in pregnancy may be an early indicator of postpartum (PP) obesity risk in WLH. Methods: The Prematurity Immunology in Mothers and their Infants Study (PIMS) enrolled pregnant PWH in…

Gestational Diabetes in South African Women With HIV on Dolutegravir: Results From the ORCHID Study

Background: Few data exist on gestational diabetes (GDM) in Africa, particularly in women with HIV (WWH) receiving dolutegravir-based antiretroviral therapy (ART). This study aimed to assess the association of HIV infection and duration on tenofovir/lamivudine/dolutegravir (TLD) with GDM. Methods: The ORCHID study enrolls WWH initiating/receiving TLD and HIV-seronegative (HIV-) women >16 years and 90) days…

Comparison of Models of Care to Promote Postpartum Viral Suppression in South African Women

Background: Maintaining viral suppression (VS) in postpartum women on antiretroviral therapy (ART) is a major concern. There is significant interest in both integrated models of service delivery for maternal and child health (MCH), and in differentiated service delivery models (DSD) postpartum, but there are few rigorous data comparing these intervention strategies. Methods: We conducted a…

A Novel Risk Calculator to Predict Sub-Optimal Outcomes Among Pregnant and Postpartum Women With HV

Background: Pregnant and postpartum women living with HIV (PPWH) experience differential treatment success. No tool currently exists to assess a PPWH’s cumulative risk of disengagement from care or treatment failure with a quantifiable score during the peripartum period. To identify PPWH at risk and intervene before negative outcomes occur, this study sought to develop and…